Why AstraZeneca may dominate the coronavirus vaccine market – The Motley Fool
All eyes have been on the leaders of the coronavirus vaccine race in recent weeks. Until there, Moderna (NASDAQ: ARNM), Pfizer (NYSE: PFE), and AstraZeneca (NASDAQ: AZN) reported efficacy data from Phase 3 trials. The United States Food and Drug Administration (FDA) will use this information, along with the safety results, to determine which players […]
The post Why AstraZeneca may dominate the…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.